Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
November 25, 2003
Embolization of a duodenal arteriovenous malformation in hereditary hemorrhagic telangiectasia: case report and review of the literature
Phil Inouye, Norman Marcon, Robin A Pugash, et al.
Headache
|
April 19, 2006
Migraines linked to intrapulmonary right-to-left shunt
John Thenganatt, Jacob Schneiderman, Robert H Hyland, et al.
Antiviral Therapy
|
July 2, 2016
Ledipasvir and sofosbuvir for HCV infection in patients coinfected with HBV
Edward J Gane, Robert H Hyland, Di An, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 16, 2017
Efficacy and Safety of Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C in Persons With Sickle Cell Disease
Juhi Moon, Robert H Hyland, Fangqiu Zhang, et al.
Gastroenterology
|
August 12, 2015
Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection
Edward J Gane, Robert H Hyland, Di An, et al.
Clinical and Translational Science
|
February 13, 2025
Pharmacokinetics of SARS-CoV-2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment
Sean Regan, Rita Humeniuk, Luzelena Caro, et al.
Chest
|
February 11, 2003
Contrast echocardiography remains positive after treatment of pulmonary arteriovenous malformations
Warren L Lee, Anthony F Graham, Robyn A Pugash, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 5, 2017
Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays
Johannes Vermehren, Marc Bourlière, Stanislas Pol, et al.
The New England Journal of Medicine
|
January 4, 2013
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C
Edward J Gane, Catherine A Stedman, Robert H Hyland, et al.
Gastroenterology
|
February 1, 2017
Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection
Edward J Gane, Robert H Hyland, Yin Yang, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
November 25, 2003
Embolization of a duodenal arteriovenous malformation in hereditary hemorrhagic telangiectasia: case report and review of the literature
Phil Inouye, Norman Marcon, Robin A Pugash, et al.
Headache
|
April 19, 2006
Migraines linked to intrapulmonary right-to-left shunt
John Thenganatt, Jacob Schneiderman, Robert H Hyland, et al.
Antiviral Therapy
|
July 2, 2016
Ledipasvir and sofosbuvir for HCV infection in patients coinfected with HBV
Edward J Gane, Robert H Hyland, Di An, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 16, 2017
Efficacy and Safety of Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C in Persons With Sickle Cell Disease
Juhi Moon, Robert H Hyland, Fangqiu Zhang, et al.
Gastroenterology
|
August 12, 2015
Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection
Edward J Gane, Robert H Hyland, Di An, et al.
Clinical and Translational Science
|
February 13, 2025
Pharmacokinetics of SARS-CoV-2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment
Sean Regan, Rita Humeniuk, Luzelena Caro, et al.
Chest
|
February 11, 2003
Contrast echocardiography remains positive after treatment of pulmonary arteriovenous malformations
Warren L Lee, Anthony F Graham, Robyn A Pugash, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 5, 2017
Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays
Johannes Vermehren, Marc Bourlière, Stanislas Pol, et al.
The New England Journal of Medicine
|
January 4, 2013
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C
Edward J Gane, Catherine A Stedman, Robert H Hyland, et al.
Gastroenterology
|
February 1, 2017
Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection
Edward J Gane, Robert H Hyland, Yin Yang, et al.
Page
of 5